CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

CMG Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	2,699	2,588	1,243	4,456	18,571	13,464
Short-Term Investments	47,539	74,206	67,585	73,357	39,000	41,000
Trading Asset Securities	24,000	-	-	-	62,003	-
Cash & Short-Term Investments	74,238	76,794	68,827	77,813	119,574	54,464
Cash Growth	46.20%	11.58%	-11.55%	-34.92%	119.54%	-4.53%
Accounts Receivable	30,441	31,312	23,320	21,330	20,291	17,261
Other Receivables	950.7	1,174	929.56	1,143	869.89	445.57
Receivables	31,392	32,486	24,250	34,542	21,161	17,706
Inventory	29,402	23,788	20,570	21,270	9,049	8,573
Prepaid Expenses	156.63	141.95	150.35	143.3	71.04	43.16
Other Current Assets	1,912	1,649	1,940	1,301	729.16	583.76
Total Current Assets	137,101	134,859	115,737	135,070	150,584	81,370
Property, Plant & Equipment	79,989	77,977	50,711	37,472	24,119	17,269
Long-Term Investments	59,419	46,463	52,565	22,996	4,003	4,657
Goodwill	2,274	2,274	2,274	-	-	-
Other Intangible Assets	2,875	2,908	3,675	3,105	1,339	1,073
Long-Term Deferred Tax Assets	3,315	3,315	2,973	2,603	2,006	2,544
Long-Term Deferred Charges	16,792	16,372	13,627	11,282	9,736	6,999
Other Long-Term Assets	331.57	291.94	456.59	621.92	455.44	468.23
Total Assets	306,209	303,437	242,098	213,260	192,243	114,380
Accounts Payable	10,580	12,013	9,197	11,245	4,328	4,163
Accrued Expenses	2,573	3,198	3,204	2,917	2,054	1,378
Short-Term Debt	45,350	880	880	-	-	-
Current Portion of Long-Term Debt	25,000	-	-	-	-	-
Current Portion of Leases	197.87	221.4	206.16	356.41	129.64	-
Current Income Taxes Payable	-	-	-	99.45	-	19.86
Other Current Liabilities	18,733	15,145	11,042	7,285	2,794	2,935
Total Current Liabilities	102,434	31,457	24,529	21,903	9,306	8,495
Long-Term Debt	10,748	78,623	24,701	6,000	-	-
Long-Term Leases	225.22	240.26	332.07	356.43	156.76	-
Other Long-Term Liabilities	2,483	2,483	1,550	48.38	1,565	1,160
Total Liabilities	118,233	113,895	51,866	28,307	12,085	10,398
Common Stock	69,446	69,446	69,446	69,446	69,446	54,444
Additional Paid-In Capital	105,846	104,889	104,641	104,641	104,812	46,786
Retained Earnings	12,312	13,894	14,219	9,000	5,055	2,309
Comprehensive Income & Other	371.16	1,313	1,926	1,866	845.23	443.09
Shareholders' Equity	187,976	189,542	190,233	184,953	180,158	103,982
Total Liabilities & Equity	306,209	303,437	242,098	213,260	192,243	114,380
Total Debt	81,521	79,965	26,119	6,713	286.39	-
Net Cash (Debt)	-7,283	-3,171	42,708	71,100	119,288	54,464
Net Cash Growth	-	-	-39.93%	-40.40%	119.02%	-4.53%
Net Cash Per Share	-52.09	-20.18	307.49	511.91	981.40	500.19
Filing Date Shares Outstanding	138.89	138.89	138.89	138.89	138.89	108.89
Total Common Shares Outstanding	138.89	138.89	138.89	138.89	138.89	108.89
Working Capital	34,667	103,402	91,208	113,167	141,278	72,875
Book Value Per Share	1353.40	1364.67	1369.64	1331.63	1297.11	954.95
Tangible Book Value	182,827	184,360	184,284	181,848	178,820	102,909
Tangible Book Value Per Share	1316.32	1327.36	1326.81	1309.28	1287.47	945.10
Land	19,574	19,574	3,985	2,709	2,709	2,709
Buildings	12,312	12,312	11,004	10,741	10,741	10,741
Machinery	19,493	19,592	18,421	16,934	14,678	13,589
Construction In Progress	47,165	44,617	34,094	22,579	7,511	1,412

Source: S&P Global Market Intelligence. Standard template. Financial Sources.